Home Hot keywords

Search Modes

全部

搜索结果

MaxCyte pdf
2020年10月28日 — MaxCyte®, ExPERT®, CARMA®, MaxCyte STx®, MaxCyte ATx®, MaxCyte GT®, MaxCyte VLX®, Flow Transfection®, Flow Electroporation®, Any Cell. Any ...
to accelerate the development of small molecule drugs, biologics and vaccines. Flow Electroporation™. Technology. Flow Electroporation™ Technology. MaxCyte's ...

2019年11月5日 — This Presentation has been issued by Maxcyte Inc (the “Company”) a Company trading on AIM, a market operated by the London Stock Exchange.
gene knock out in T- and NK-cells using MaxCyte's clinically-validated, non-viral platform. Additionally, we highlight strategies for how this approach can ...
1 页·433 KB
The Investor Relations website contains information about MaxCyte Inc's business for stockholders, ... Enter the password to open this PDF file:.
The MaxCyte STX uses a proprietary, scalable electroporation technology to (co)transfect a variety of cell types, including primary cells, with DNA, RNA, siRNA, ...
1 页·850 KB
2019年11月19日 — Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for. Engineered Hematopoietic Stem Cells (eHSCs) to Treat ...
Improve Your Biomanufacturing Using the Ultimate Transfection Platform. The MaxCyte VLX® Large Scale Transfection System is a small-footprint, ...
作者:B Salmons2014 — Maxcyte, Gaitherburg, Maryland, United States. Gene editing offers a promising method for developing potential treatments for monogeneic diseases.
MaxCyte. Overview: Arguably the best-established transfection approach, electroporation has been widely used in both research and industry for many years.

Page Navigation

google search trends